Real Chemistry

What Real Chemistry does

Real Chemistry is a private, PE-backed healthcare commercialization and communications firm founded in 2001 and headquartered in New York, with FY2025 revenue of $560 million (14% year-over-year growth) and 2,400+ global employees across 30+ countries. The company operates as a tier-one commercialization partner to the pharmaceutical and biotechnology industries, serving all of the top 20 pharma companies and 56 of the top 100 pharma brands through dedicated enterprise account leadership and integrated cross-functional teams.

The company's core offering is an AI-powered audience analytics and omnichannel orchestration platform — built on a proprietary stack enhanced via AWS (Amazon SageMaker) and Databricks — that enables real-time personalization, next-best-action deployment, closed-loop measurement, and AI-driven HCP/patient engagement. Named proprietary capabilities include Compliance Compass (AI analysis of FDA enforcement letters), the AI-powered Audience Proxy (90% accuracy in predicting HCP preferences across 230,000+ data points), Generative Engine Optimization (GEO) for tracking brand visibility in AI assistants, and the unified Real Chemistry Media omnichannel offering. The brand portfolio also includes 21GRAMS (a Cannes Lions Top 5 creative health agency), starpower (HCP influencer practice), and the newly launched RC Resolve advisory practice.

Real Chemistry generates revenue through professional services delivered on a project-based and retainer basis to enterprise pharma and biotech clients, with go-to-market executed through direct enterprise sales. Recent strategic activity has been characterized by aggressive inorganic expansion: three acquisitions in 24 months (Avant Healthcare Feb 2024, Greater Than One July 2025, Spring & Bond Oct 2025), the June 2026 launch of Real Chemistry Media unifying these assets, new regional hubs in Dubai, Munich, and Zurich, and a $3.1 billion continuation vehicle established by sponsor New Mountain Capital in May 2026. The company is privately held and led by CEO Shankar Narayanan, who succeeded founder Jim Weiss in January 2022.

Name

Real Chemistry

Legal name

Real Chemistry, LLC

Website

https://realchemistry.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Real Chemistry is a PE-backed, AI-powered healthcare commercialization and communications firm serving all top 20 pharma companies through enterprise audience analytics, omnichannel orchestration, medical communications, and creative services across 30+ countries.

Ownership category

akta.pro rank

Product category

Healthcare Marketing & Communications

akta.pro primary industry

Healthcare & Life Sciences PR (MPAAADAD)

akta.pro secondary industries

Healthcare/Pharma Creative Agencies (MPAAAAAJ), Healthcare & Life Sciences PR (BPAFADAJ), Medical Affairs Scientific Communications (MSL Support/Scientific Response) (HLAGALAF)

Keywords

• Healthcare communications services
• Pharmaceutical marketing analytics
• Medical communications strategy
• Omnichannel healthcare media
• Healthcare commercialization AI

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices29 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

1. Healthcare Marketing and Communications Services: Professional services providing AI-powered audience analytics, insights, medical communications, creative development, and omnichannel marketing solutions to pharmaceutical and healthcare companies.
2. Media and Omnichannel Activation: Integrated media services including precision media, paid media, and omnichannel campaign management for healthcare brands.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Real Chemistry is a global healthcare communications network providing AI-powered audience analytics, medical communications, creative development, precision media, and omnichannel marketing solutions to pharmaceutical and life sciences companies. The firm connects complex science with world-class storytellers to help life-changing medicines reach their full market potential, serving all top 20 pharma companies through 2,400+ experts across 30+ countries.

Product overview

Real Chemistry is an AI-powered healthcare analytics and marketing platform structured as a core platform with specialized sub-brands and modular capabilities. The core Real Chemistry platform provides AI-powered audience analytics, omnichannel orchestration (via Real Chemistry Media), and healthcare commercialization services. The brand portfolio includes 21GRAMS (award-winning creative agency) and starpower (celebrity/influencer practice). Proprietary AI capabilities include the omnichannel orchestration platform enhanced through AWS/SageMaker, Compliance Compass (FDA letter analysis), RC Resolve (advisory intelligence), and HealthGEO Pulse (GEO insights). The company also partners with Doceree's Daily Command platform for pharma commercialization. Services span medical communications, precision media, data/analytics, creative development, and regulatory-compliant AI solutions.

Differentiator

Problem solved

Functional benefit

Brands

• 21GRAMS: Highly awarded creative agency; ranked Top 5 Most Creative Health Agency in the World by Cannes Lions; part of Real Chemistry's brand portfolio
• starpower
• Real Chemistry Media
• RC Resolve

Products and services

• Real Chemistry Media Unified media and omnichannel offering for healthcare marketers integrating Spring & Bond, Greater Than One, and legacy media operations. Provides end-to-end omnichannel solutions with approximately 450 media experts and 150+ data/analytics professionals, designed for pharmaceutical and healthcare brand customer engagement at scale.
• Compliance Compass AI-based system that analyzes FDA enforcement letters to identify marketing compliance trends, helping pharmaceutical companies proactively adapt their marketing strategies by recognizing common violations in highly regulated environments.
• RC Resolve Healthcare advisory practice designed to help healthcare leaders navigate critical business, regulatory, and value inflection points. Offers insight, influence, and action through proprietary AI-powered intelligence and seasoned industry experts.
• HealthGEO Pulse Monthly AI search and Generative Engine Optimization (GEO) briefing tailored for pharmaceutical and healthcare leaders, providing insights on how AI assistants like ChatGPT and OpenEvidence surface information about brands, trials, and therapy areas.
• 21GRAMS Creative Agency Highly awarded healthcare creative agency ranked as Top 5 Most Creative Health Agency in the World by Cannes Lions. Part of Real Chemistry's brand portfolio focusing on creative that redefines what is possible in highly regulated healthcare environments.
• starpower Celebrity and influencer practice within Real Chemistry's portfolio, specializing in identifying physicians and influencers shaping clinical conversations and building peer-to-peer programs for oncology and healthcare brand engagement.

Quantifiable outcome

• Double the rate of growth for clients who worked with Real Chemistry compared to those who did not
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability13 records

Feature4 records

Partnerships

Nine partnerships are on record, tiered core, flagship and minor.

• Amazon Web Services (AWS)coreTechnology or Integration · 18 June 2026Real Chemistry Media is collaborating with AWS to enhance its proprietary omnichannel orchestration platform using AWS cloud and AI services, including Amazon SageMaker. The collaboration aims to improve platform performance and scalability for healthcare engagement.
• DocereeflagshipStrategic or Co-development Partner · 7 May 2026Real Chemistry participated as one of 75 senior operators co-building Doceree's Daily Command, an AI-powered operating system for healthcare marketing. Real Chemistry contributed to defining a new $30 billion software category for pharmaceutical brand teams.
• SanofiminorStrategic or Co-development Partner · 7 May 2026Sanofi participated as one of the major pharmaceutical manufacturers co-building Doceree's Daily Command platform with 75 senior industry operators.
• MerckminorStrategic or Co-development Partner · 7 May 2026Merck participated as one of the major pharmaceutical manufacturers co-building Doceree's Daily Command platform with 75 senior industry operators.
• Bristol Myers SquibbminorStrategic or Co-development Partner · 7 May 2026Bristol Myers Squibb participated as one of the major pharmaceutical manufacturers co-building Doceree's Daily Command platform with 75 senior industry operators.
• Eli LillyminorStrategic or Co-development Partner · 7 May 2026Eli Lilly participated as one of the major pharmaceutical manufacturers co-building Doceree's Daily Command platform with 75 senior industry operators.
• DatabrickscoreTechnology or Integration · 5 March 2026Real Chemistry adopted the Databricks platform with Databricks Apps to scale access to advanced AI capabilities. Implementation reduced proof-of-concept development timelines from months to days while enabling non-technical analysts to self-serve AI-powered insights.
• American Medical AssociationminorGTM or Marketing Partner · 23 October 2025AMA collaborated with Ad Council and a coalition of healthcare leaders including Real Chemistry to launch a digital resource hub for firearm injury prevention.
• Ad CouncilminorGTM or Marketing Partner · 23 October 2025Ad Council partnered with AMA and healthcare leaders including Real Chemistry to launch a digital resource hub for firearm injury prevention at AgreeToAgree.org/HealthCare.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• EVERSANA: Independent life sciences commercial services firm spanning data, patient services, field deployment, and commercialization strategy. Broader scope than Real Chemistry but competes at the interface of pharma commercialization, analytics, and marketing technology.
• Syneos Health: Clinical and commercial services organization (now publicly held with PE involvement) offering clinical research plus commercial and patient solutions. Overlaps with Real Chemistry on the pharmaceutical commercialization and medical communications dimension despite primary CRO focus.

Direct peers

• Omnicom Health Group: The largest dedicated global healthcare communications network, operating agencies across advertising, medical communications, public relations, and health media planning. Direct competitor to Real Chemistry in winning tier-one pharma commercialization mandates and serving top-20 pharma clients globally.
• Havas Health Network: Integrated Havas network focused exclusively on health and wellness, spanning creative, media, and patient engagement. Direct competitor in healthcare marketing for top pharma brands with comparable AI-augmented creative and media offerings.
• Inizio Medical (Fishawack Health): Medical communications and commercialization services group within Inizio, covering medical affairs, publications, and healthcare marketing. Direct comparable on the medical communications side that competes with Real Chemistry's Avant Healthcare practice.
• Publicis Health: Healthcare-focused network within Publicis Groupe providing healthcare advertising, communications, media, and digital transformation to top pharma clients. Competes head-to-head with Real Chemistry for global pharma brand commercialization and launch work.
• Klick Health: Large independent healthcare marketing agency offering strategy, creative, medical, and data-driven omnichannel campaigns for pharma brands. Comparable to Real Chemistry's independent, full-service positioning with strong AI/data emphasis and top-pharma client roster.
• VML Health (WPP): Healthcare and life sciences offering within WPP's VML network, providing brand experience, communications, and data-driven marketing to pharma and health brands. Direct competitor for global pharma mandates within the broader WPP healthcare portfolio.
• Evoke Group: Specialist health and wellness marketing communications group offering brand strategy, advertising, public relations, and patient engagement. Closely comparable in serving top pharma and biotech clients with integrated communications capabilities.

Emerging players

• Doximity: Digital platform for healthcare professionals with growing marketing solutions and HCP audience analytics. Adjacent peer where it increasingly competes with Real Chemistry's HCP-targeting capabilities such as the AI-powered Audience Proxy and precision media offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/RealChemistry_
• LinkedInlinkedin.com/company/therealchemistry
• Facebookfacebook.com/TheRealChemistry

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Subsidiaries12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Real Chemistry